World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
82
Citations
23638
World Ranking
16166
National Ranking
1486

Overview

Michael Brada is affiliated with the University of Liverpool in the United Kingdom. Their research primarily focuses on fields related to medicine, with an emphasis on radiology, nuclear medicine and imaging, pulmonary and respiratory medicine, radiation, oncology, and epidemiology.

The scientist's main research topics cover lung cancer diagnosis and treatment, advanced radiotherapy techniques, effects of radiation exposure, medical imaging techniques and applications, pancreatic and hepatic oncology research, radiomics and machine learning in medical imaging, as well as meningioma and schwannoma management.

Michael Brada has contributed to several academic publications. Recent papers include:

  • "ESTRO ACROP guideline for target volume delineation of skull base tumors," 2020, Radiotherapy and Oncology
  • "Improving Outcomes in NSCLC: Optimum Dose Fractionation in Radical Radiotherapy Matters," 2022, Journal of Thoracic Oncology
  • "Afatinib and radiotherapy, with or without temozolomide, in patients with newly diagnosed glioblastoma: results of a phase I trial," 2021, Journal of Neuro-Oncology
  • "Cardiac-sparing radiotherapy for locally advanced non-small cell lung cancer," 2021, Radiation Oncology
  • "Dyspnea in Patients Receiving Radical Radiotherapy for Non-Small Cell Lung Cancer: A Prospective Study," 2020, Frontiers in Oncology

The scientist frequently collaborates with others in their field. Notable co-authors include:

  • John D. Fenwick
  • Helen Forbes
  • S. Ashley
  • Louise Turtle
  • Neeraj Bhalla

Michael Brada's work has been published repeatedly in several venues. Frequent publication journals include:

  • Journal of Thoracic Oncology
  • Radiotherapy and Oncology
  • Radiation Oncology
  • Journal of Neuro-Oncology
  • Frontiers in Oncology

Best Publications

  • A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

    W K A Yung;R E Albright;J Olson;R Fredericks

  • Multicenter Phase II Trial of Temozolomide in Patients With Anaplastic Astrocytoma or Anaplastic Oligoastrocytoma at First Relapse

    W. K.Alfred Yung;Michael D. Prados;Ricardo Yaya-Tur;Steven S. Rosenfeld

  • High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    R. Stupp;M. Brada;M. J. van den Bent;J.-C. Tonn

  • Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma.

    M. Brada;D. Ford;S. Ashley;J. M. Bliss

  • Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: update after an additional 10 years.

    G. Minniti;D. Traish;S. Ashley;A. Gonsalves

  • The long‐term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas

    M. Brada;B. Rajan;D. Traish;S. Ashley

  • Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse

    M. Brada;K. Hoang-Xuan;R. Rampling;P. Y. Dietrich

  • Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO).

    Riccardo Soffietti;Ufuk Abacioglu;Brigitta Baumert;Stephanie E Combs

  • High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    R. Stupp;J.-C. Tonn;M. Brada;G. Pentheroudakis

  • Nurse led follow up and conventional medical follow up in management of patients with lung cancer: randomised trial

    Sally Moore;Jessica Corner;Jo Haviland;Mary Wells

  • Craniopharyngioma — long-term results following limited surgery and radiotherapy

    B. Rajan;S. Ashley;C. Gorman;C.C. Jose

  • The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires

    D. Osoba;N. K. Aaronson;M. Muller;K. Sneeuw

  • ESTRO-ACROP guideline "target delineation of glioblastomas"

    Maximilian Niyazi;Michael Brada;Anthony J Chalmers;Stephanie E Combs

  • Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas

    M. Brada;L. Viviers;C. Abson;F. Hines

  • Relocatable frame for stereotactic external beam radiotherapy.

    S.S. Gill;D.G.T. Thomas;A.P. Warrington;M. Brada

  • Temozolomide Versus Procarbazine, Lomustine, and Vincristine in Recurrent High-Grade Glioma

    Michael Brada;Sally Stenning;Rhian Gabe;Lindsay C. Thompson

  • Health-Related Quality of Life in Patients Treated With Temozolomide Versus Procarbazine for Recurrent Glioblastoma Multiforme

    David Osoba;M. Brada;W. K.A. Yung;M. Prados

  • Phase I dose-escalation and pharmacokinetic study of temozolomide (SCH 52365) for refractory or relapsing malignancies.

    M Brada;I Judson;P Beale;S Moore

  • Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma.

    M. Bower;E. S. Newlands;N. M. Bleehen;M. Brada

  • Pathology and Genetics of Tumours of the Nervous System

    Michael Brada

Frequent Co-Authors

Stanley W. Ashley
Stanley W. Ashley Brigham and Women's Hospital
Alan Horwich
Alan Horwich Royal Marsden NHS Foundation Trust
Vincent Khoo
Vincent Khoo Royal Marsden NHS Foundation Trust
David Osoba
David Osoba University of British Columbia
Dirk De Ruysscher
Dirk De Ruysscher Maastricht University
Michael D. Prados
Michael D. Prados University of California, San Francisco
Michael Weller
Michael Weller University of Zurich
Ian Judson
Ian Judson Institute of Cancer Research
Douglas F. Easton
Douglas F. Easton University of Cambridge
Zoltan Szallasi
Zoltan Szallasi Boston Children's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re exploring a career in healthcare alongside or beyond traditional medical studies, there are several accessible online degree options worth considering. For example, those seeking a nursing path might explore the easiest nursing schools to get into, which offer flexible entry requirements and may help you start your career faster.

Not everyone aiming to work in healthcare needs direct patient contact. Those interested in administrative or behind-the-scenes roles might consider medical billing and coding schools online with financial aid. These programs can open doors to in-demand positions that support medical facilities nationwide.

If testing requirements like the TEAS or HESI exams are a concern, it’s possible to find do i need to take the teas test for lpn – resources that explain which programs offer more flexible admissions criteria.

For those interested in management or leadership, pursuing a health care administration degree online can prepare you to oversee clinics, hospitals, or health systems. These degree pathways can expand your impact within the growing healthcare industry, all while studying from the comfort of your home.

Best Scientists Citing Michael Brada

Trending Scientists